Blindness News and Research

RSS

New inhibitor drug shows promise in preventing diabetic eye and kidney disease

New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease.

2 Feb 2024

MACUSTAR extends Europe-wide clinical study on intermediate age-related macular degeneration

The MACUSTAR consortium is extending the duration of a Europe-wide clinical study on age-related macular degeneration (AMD) under the coordination of the Department of Ophthalmology at the University Hospital Bonn (UKB).

2 Feb 2024

Does visual impairment influence mental disorders?

Whether visual impairment (VI) affects mental disorders in the older population.

31 Jan 2024

New study of daylight vision using canine model offers critical insight into restoring cone function

In the retinas of human eyes, the cones are photoreceptor cells responsible for color vision, daylight vision, and the perception of small details.

27 Jan 2024

StemSight and ERS Genomics focus on collaboration

License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness.

17 Jan 2024

Night-time artificial light exposure linked to increased risk of age-related macular degeneration

A study in South Korea finds that higher exposure to outdoor artificial light at night significantly increases the risk of developing exudative age-related macular degeneration.

16 Jan 2024

First organoid model of the human conjunctiva produced

The Organoid group at the Hubrecht Institute produced the first organoid model of the human conjunctiva. These

11 Jan 2024

Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment

Researchers developed an advanced prime editor-engineered virus-like particle (PE-eVLP) system, significantly enhancing gene editing efficiency in human cells and showing potential for treating genetic diseases.

9 Jan 2024

IU researchers aim to develop a new therapy for glaucoma

Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma, a complex disease that eventually leads to blindness, thanks to a new five-year, $2 million R01 grant from the National Eye Institute.

8 Jan 2024

Engineered virus-like particles power up gene editing, correcting blindness in mice

Prime editing, a versatile form of gene editing that can correct most known disease-causing genetic mutations, now has a new vehicle to deliver its machinery into cells in living animals.

8 Jan 2024

Can AI predict diabetic eye disease progression?

"DeepDR Plus," a deep learning system, accurately predicts diabetic retinopathy progression up to five years using fundus images, offering potential for personalized screening and management in diabetic patients.

7 Jan 2024

AI Integration in the Fight Against Age-Related Macular Degeneration

In this interview, Wen Hwa Lee, CEO, and Chief Scientist at Action Against Age-Related Macular Degeneration (AAAMD), offers an enlightening perspective on merging AI with ophthalmology to forge new paths in healthcare and drug discovery.

From ELRIG (UK) Ltd. 3 Jan 2024

Study identifies α-MSH as therapeutic candidate for corneal endothelial disease

Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.

2 Jan 2024

Champagne cork related eye injuries can be a substantial threat to eye health

Be careful this holiday season, warn researchers in the Christmas issue of The BMJ. Eye injuries while opening bottles of fizz can be significant and easily avoided.

21 Dec 2023

Machine learning predicts the long-term future of shortsighted eyes

Machine learning has been found to predict well the outcomes of many health conditions. Now, researchers from Japan have found a way to predict whether people with severe shortsightedness will have good or bad vision in the future.

13 Dec 2023

Use of artificial intelligence to diagnose lagophthalmos

A convolutional neural network (CNN) to automate lagophthalmos diagnosis.

12 Dec 2023

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

Researchers have discovered the novel mechanism that underlies a previously reported observation that infection by group A Streptococcus bacteria reduces the risk of later developing Type 1 diabetes.

5 Dec 2023

Researchers identify a promising new strategy for glaucoma cell replacement therapy

Glaucoma is one of the leading causes of blindness worldwide, and vision loss, due to the loss of retinal ganglion cells (RGCs), cannot currently be reversed with any treatment.

17 Nov 2023

Complex genetics behind human cranial vault shape revealed

Researchers at the University of Pittsburgh and KU Leuven have discovered a suite of genes that influence head shape in humans.

17 Nov 2023

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

A combined $1.35 million from the Dr. Ralph and Marian Falk Medical Research Trust was awarded to two researchers from the Case Western Reserve University School of Medicine to advance their work on finding more effective treatments-;and better options-;for two debilitating diseases.

17 Nov 2023

Blindness News and Research

New inhibitor drug shows promise in preventing diabetic eye and kidney disease

MACUSTAR extends Europe-wide clinical study on intermediate age-related macular degeneration

Does visual impairment influence mental disorders?

New study of daylight vision using canine model offers critical insight into restoring cone function

StemSight and ERS Genomics focus on collaboration

Night-time artificial light exposure linked to increased risk of age-related macular degeneration

First organoid model of the human conjunctiva produced

Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment

IU researchers aim to develop a new therapy for glaucoma

Engineered virus-like particles power up gene editing, correcting blindness in mice

Can AI predict diabetic eye disease progression?

AI Integration in the Fight Against Age-Related Macular Degeneration

Study identifies α-MSH as therapeutic candidate for corneal endothelial disease

Champagne cork related eye injuries can be a substantial threat to eye health

Machine learning predicts the long-term future of shortsighted eyes

Use of artificial intelligence to diagnose lagophthalmos

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

Researchers identify a promising new strategy for glaucoma cell replacement therapy

Complex genetics behind human cranial vault shape revealed

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News